Back to Search
Start Over
Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes
- Source :
- Leukemia & Lymphoma. 63:463-467
- Publication Year :
- 2021
- Publisher :
- Informa UK Limited, 2021.
- Subjects :
- Cancer Research
Oncology
Hematology
Subjects
Details
- ISSN :
- 10292403 and 10428194
- Volume :
- 63
- Database :
- OpenAIRE
- Journal :
- Leukemia & Lymphoma
- Accession number :
- edsair.doi...........06962155665e6e769eb21bfa46208fc3